Novartis Succeeds in Patent Infringement Lawsuits Related to Vidagliptin.
Novartis had filed multiple qua timet patent infringement lawsuits against a number of generic companies including Biocon, Glenmark, Wockhardt Ajanta Pharma etc. and has managed to secure several interim injunctions against these generic companies. In 37 of these infringement lawsuits, Novartis either secured an interim injunction or a settlement from the defendant making this series